Aromatase Inhibition and Breast Cancer and over one million other books are available for Amazon Kindle. Learn more


or
Sign in to turn on 1-Click ordering.
or
Amazon Prime Free Trial required. Sign up when you check out. Learn More
More Buying Choices
Have one to sell? Sell yours here
Aromatase Inhibition and Breast Cancer
 
 
Start reading Aromatase Inhibition and Breast Cancer on your Kindle in under a minute.

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Aromatase Inhibition and Breast Cancer [Hardcover]

William R. Miller (Editor), Richard Santen (Editor)

Price: $159.95 & this item ships for FREE with Super Saver Shipping. Details
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.
Only 1 left in stock--order soon (more on the way).
Want it delivered Tuesday, February 14? Choose One-Day Shipping at checkout. Details
Textbook Student FREE Two-Day Shipping for students on millions of items. Learn more

Formats

Amazon Price New from Used from
Kindle Edition $135.96  
Hardcover $159.95  

Book Description

January 15, 2001 0824704126 978-0824704124 1st

Presents evidence that letrozole, anastrozole, and exemestane have proven efficacy as second-line therapy and indicate increased antitumor effects and less toxicity than older aromatase inhibitors and progestins! This reference provides a state-of-the-art assessment of drugs that inhibit the synthesis of estrogens-particularly agents used to treat breast cancer-and demonstrates how the endocrinological effects of the new generation of inhibitors translate into clinical benefits. Highlights recent key research aimed at developing novel reagents and technology to optimize drug therapies and expand their clinical applications. With contributions from over 75 international experts, Aromatase Inhibition and Breast Cancer · reviews the preclinical development of aromatase inhibitors and their place in the current practice of breast cancer management · considers aromatase inhibitors for early stages of breast cancer as an adjuvant to surgery · explains how machine learning techniques accurately identify tumors likely to respond to treatment · gives an immunohistological evaluation of aromatase protein and RT-PCR measurements at the level of mRNA · describes how model systems based on human material have optimized the use and demonstrated the potential of aromatase inhibitors · presents the case for employing aromatase inhibitors to treat pubertal gynecomastia, prostate cancer, and benign and malignant endometrial conditions · and more! Given the remarkable endocrine effects and the clinical potential of the new generation of aromatase inhibitors, Aromatase Inhibition and Breast Cancer is an essential reference for oncologists, endocrinologists, gynecologists, obstetricians, pharmacologists, family physicians, reproductive biologists, and medical school students in these disciplines.


Product Details


Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Inside This Book (learn more)
First Sentence:
The goal of developing highly effective, well-tolerated, orally active aromatase inhibitors was set about 20 years ago after the recognition that inhibition of aromatase was the principal mode of action of the breast cancer drug aminoglutethimide (AG). Read the first page
Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
aromatase immunohistochemistry, breast adipose tissue fibroblasts, intratumoral aromatase model, previous antiestrogen therapy, endometriotic stromal cells, letrozole treatment, following tamoxifen failure, aromatase immunoreactivity, letrozole group, intratumoral aromatase activity, aromatase inhibitor therapy, neoadjuvant endocrine therapy, endocrine modalities, new oral aromatase inhibitor, aromatase expression, comparing letrozole, pubertal gynecomastia, primary endocrine therapy, tumor aromatase, aromatase inhibitors, aromatase protein, estrogen suppression, postmenopausal endometriosis, eutopic endometrium, aromatase levels
Key Phrases - Capitalized Phrases (CAPs): (learn more)
Cancer Res, Clin Oncol, Mitch Dowsett, Clin Endocrinol Metab, William Miller, Panel Discussion, Ian Smith, Paul Goss, Ajay Bhatnagar, Henning Mouridsen, Ann Oncol, Collaborative Group, Harold Harvey, Michael Dixon, Serdar Bulun, Suzanne Wait, Endocr Rel Cancer, Natl Cancer Inst, Matthew Smith, Stephen Johnston, Angela Brodie, Steroid Biochem Mol Biol, Dean Evans, Arnold Verbeek, Carsten Rose
New!
Books on Related Topics | Concordance | Text Stats
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Search Inside This Book:




Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject